Safety Study of Hepatitis E Vaccine (HEV239)

NCT03827395 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Hepatitis E
Immunisation

Interventions

BIOLOGICAL: HEV 239
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)